πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7709609

Tumor suppressor gene, p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691579

Methods and compositions for producing an enhanced immune response to a human papillomavir

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691386

Chimeric papillomavirus-like particles

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7682618

Generation of virus-like particles and use as panfilovirus vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678828

Methods for the formulation and manufacture of artesunic acid for injection

The United States of America as represented by the Secretary of the Army Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666427

HIV vaccines based on Env of multiple clades of HIV

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666674

Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotide

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666404

Glanders/meliodosis vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662619

Sol-fusin: use of GP64-6His to catalyze membrane fusion

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662999

Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors

The United States of America as represented by the Department of Health and Human Services (DHHS) Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662568

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659115

Nucleic acid encoding human transductin-1 polypeptide

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659081

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655752

TNF-Ξ± converting enzyme inhibitory agents and method of using same

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638134

Insertion sites in fowlpox vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638333

Anthrax vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635476

Anti-hepatitis a virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632659

Use of Shigella invaplex to transport functional proteins and transcriptionally active nuc

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7625571

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618623

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618632

Method of treating or ameliorating an immune cell associated pathology using GITR ligand a

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7615227

Use of CpG oligodeoxynucleotides to induce angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608422

Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhib

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605127

Truncated hepatocyte growth factor variant protein HGF/NK2

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted